Akebia Therapeutics files 8-K on delisting notice or failure to satisfy listing rule

Akebia Therapeutics, Inc. filed a Form 8-K with the SEC on 2026-10-23, disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing.

Detected & updated continuously · Source: Nebula